Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Background: The incidence of renal immune-related adverse events (irAEs) is reported to be 3.8%, with varied definitions of acute kidney injury (AKI). This study reports a 10-year experience at MD Anderson Cancer Center of patients diagnosed with melanoma and treated with immune checkpoint inhibitor...

詳細記述

書誌詳細

出版年:	OncoImmunology
主要な著者:	Maen Abdelrahim, Omar Mamlouk, Heather Lin, Jamie Lin, Valda Page, Noha Abdel-Wahab, Joshua Swan, Umut Selamet, Cassian Yee, Adi Diab, Wadi Suki, Ala Abudayyeh
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2021-01-01
主題:	acute kidney injury immune checkpoint inhibitor melanoma survival
オンライン･アクセス:	http://dx.doi.org/10.1080/2162402X.2021.1927313